Amundi UK Equity All Cap UCITS ETF | LCUKRegister to Unlock Ratings |
Performance History | 30/11/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -11.4 | 18.3 | 1.2 | 7.5 | 11.1 | |
+/-Cat | -2.3 | 0.4 | 3.3 | -0.7 | 1.1 | |
+/-B’mrk | - | - | - | -0.1 | -0.1 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
Closing Price 17/12/2024 | GBX 1140.90 | |
Day Change | -0.85% | |
Morningstar Category™ | UK Large-Cap Equity | |
Volume | 16061 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1781541096 | |
Fund Size (Mil) 17/12/2024 | GBP 442.51 | |
Share Class Size (Mil) 17/12/2024 | GBP 442.51 | |
Ongoing Charge 27/09/2024 | 0.04% |
Investment Objective: Amundi UK Equity All Cap UCITS ETF | LCUK |
The investment objective of the Sub-Fund is to track both the upward and the downward evolution of the Morningstar UK NR Index (the "Index") denominated in GBP and representative of the United Kingdom’s large and mid cap equity market - while minimizing the volatility of the difference between the return of the Sub-Fund and the return of the Index (the “Tracking Error”). The anticipated level of the tracking error under normal market conditions is expected to be up to 0.50%. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Armine Matevosyan 27/02/2018 | ||
Raphaël Dieterlen 27/02/2018 | ||
Inception Date 27/02/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Morningstar UK NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi UK Equity All Cap UCITS ETF | LCUK | 16/12/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.22 |
Shell PLC | Energy | 6.80 |
HSBC Holdings PLC | Financial Services | 6.24 |
Unilever PLC | Consumer Defensive | 5.09 |
RELX PLC | Industrials | 3.08 |
Increase Decrease New since last portfolio | ||
Amundi UK Equity All Cap UCITS ETF | LCUK |